Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWhitbread Regulatory News (WTB)

Share Price Information for Whitbread (WTB)

Share Price is delayed by 15 minutes
Get Live Data
2,340.00    1.00 (0.04%)
Bid:
2,342.00
Ask:
2,344.00
Spread: 2.00 (0.085%)
Market Cap: £3.91b
WTB Live PriceLast checked at - London Stock Exchange

Intraday Whitbread Share Chart

Share repurchase programme

18 Oct 2023 07:10

RNS Number : 4430Q
Whitbread PLC
18 October 2023
 

 

 

 

SHARE REPURCHASE PROGRAMME

 

 

As announced in today's interim results announcement, Whitbread PLC ('Whitbread' or the 'Company') is commencing a share buy-back programme of up to £300 million (the 'Programme'). The purpose of the Programme is to reduce the capital of Whitbread by returning surplus capital to shareholders and it is expected that the implementation of the Programme will enhance earnings per share. Whitbread has instructed Morgan Stanley & Co. International Plc ('Morgan Stanley') and J.P. Morgan Securities plc ('JPMS'), together the 'Brokers', to execute the Programme.

 

Whitbread has entered into a non-discretionary and irrevocable instruction with Morgan Stanley in relation to the purchase by Morgan Stanley, acting as riskless principal during the period commencing today and ending no later than 23 January 2024, of the Company's Ordinary Shares of 76 122/153 pence each ('Ordinary Shares') for an aggregate purchase price of up to £150 million. Following completion, or any termination of such instruction, the Programme will continue under a second non-discretionary and irrevocable instruction with JPMS) in relation to the purchase by JPMS, acting as riskless principal during the period commencing following the end of the Morgan Stanley instruction and ending no more than three months later, subject to suspension for certain exceptional and/or unforeseen circumstances, of further Ordinary Shares for an aggregate purchase price of up to £150 million.

 

The aggregate purchase price of the Ordinary Shares bought by the Brokers under the two instructions shall be no greater than £300 million. Each of the Brokers shall make a simultaneous on-sale of Ordinary Shares purchased under the instructions to Whitbread. The Brokers will make their trading decisions in relation to the Programme independently of, and uninfluenced by, Whitbread.

 

The maximum number of Ordinary Shares that can be purchased under the Programme is 14,138,162 Ordinary Shares (based on authority granted at Whitbread's 2023 Annual General Meeting).

 

Any purchase of Ordinary Shares made by the Brokers in relation to the Programme will be carried out on the London Stock Exchange plc, Cboe Europe Limited or Aquis Stock Exchange Limited. The buy-back by Whitbread will be executed in accordance with the Listing Rules and Whitbread's general authority (from time to time) to make market purchases of Ordinary Shares. The Programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Whitbread will announce any purchase by it of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary Shares purchased under the Programme will be cancelled or (to the extent permitted by law) held in treasury.

 

The Brokers may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the period of the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by the relevant Broker as a result of or as part of the Programme, but the Brokers will continue to make any disclosures they are otherwise legally required to make.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For more information please contact:

Investor Relations - Whitbread investorrelations@whitbread.com

 

Media - Teneo whitbread@teneo.com

Jessica Reid +44 (0) 20 7353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSMRBRTMTABBBJ
Date   Source Headline
18th Jun 20203:59 pmRNSDirector/PDMR Shareholding
16th Jun 202011:34 amRNSDirector/PDMR Shareholding
15th Jun 20202:28 pmRNSHolding(s) in Company
15th Jun 20201:53 pmRNSDirector/PDMR Shareholding
12th Jun 20204:13 pmRNSDirector/PDMR Shareholding
12th Jun 20204:02 pmRNSDirector/PDMR Shareholding
11th Jun 20204:49 pmRNSTotal Voting Rights
10th Jun 20202:59 pmRNSHolding(s) in Company
10th Jun 202011:18 amRNSSuccessful Placing of Rights Issue Rump
10th Jun 20207:00 amRNSResults of Rights Issue
3rd Jun 20208:25 amRNSAnnual General Meeting
2nd Jun 20202:11 pmRNSHolding(s) in Company
1st Jun 202012:09 pmRNSTotal Voting Rights
28th May 20209:37 amRNSHolding(s) in Company
27th May 20204:17 pmRNSHolding(s) in Company
21st May 202012:19 pmRNSPublication of a Prospectus
21st May 20207:00 amRNSRights Issue
21st May 20207:00 amRNSPreliminary Results Announcement
1st May 202011:43 amRNSTotal Voting Rights
30th Apr 20208:18 amRNSDirector Declaration
24th Apr 20207:00 amRNSFY20 full year results announcement timing
20th Apr 202010:05 amRNSHolding(s) in Company
17th Apr 20207:00 amRNSCovid Corporate Financing Facility
7th Apr 202011:43 amRNSHolding(s) in Company
2nd Apr 20209:26 amRNSHolding(s) in Company
1st Apr 20203:08 pmRNSTotal Voting Rights
27th Mar 20204:38 pmRNSHolding(s) in Company
27th Mar 20209:08 amRNSHolding(s) in Company
26th Mar 20209:09 amRNSDirector Declaration
24th Mar 20203:04 pmRNSHolding(s) in Company
24th Mar 20202:40 pmRNSCovid-19 Update
2nd Mar 20203:49 pmRNSTotal Voting Rights
2nd Mar 202011:44 amRNSHolding(s) in Company
28th Feb 20207:00 amRNSAcquisition in Germany
26th Feb 20204:26 pmRNSDirector Declaration
26th Feb 20203:34 pmRNSHolding(s) in Company
25th Feb 20202:30 pmRNSHolding(s) in Company
24th Feb 20203:54 pmRNSDirector/PDMR Shareholding
18th Feb 20204:16 pmRNSDirector/PDMR Shareholding
18th Feb 20204:13 pmRNSDirector/PDMR Shareholding
5th Feb 20204:14 pmRNSDirector/PDMR Shareholding
3rd Feb 202011:48 amRNSTotal Voting Rights
27th Jan 20208:49 amRNSDirector/PDMR Shareholding
27th Jan 20208:49 amRNSBlock listing Interim Review
16th Jan 202011:56 amRNSDirector/PDMR Shareholding
16th Jan 20207:00 amRNSQ3 FY20 Trading Update
2nd Jan 202010:20 amRNSTotal Voting Rights
17th Dec 201911:46 amRNSDirector/PDMR Shareholding
13th Dec 20194:11 pmRNSDirector/PDMR Shareholding
13th Dec 20194:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.